{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:16:40Z","timestamp":1790749000741,"version":"4.1.0"},"reference-count":36,"publisher":"American Society of Hematology","issue":"23","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,12,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Mastocytosis is a heterogeneous disease characterized by an abnormal accumulation of mast cells (MCs) in 1 or several organs. Although a somatic KIT D816V mutation is detected in \u223c85% of patients, attempts to demonstrate its oncogenic effect alone have repeatedly failed, suggesting that additional pathways are involved in MC transformation. From 3 children presenting with both Greig cephalopolysyndactyly syndrome (GCPS, Mendelian Inheritance in Man [175700]) and congenital mastocytosis, we demonstrated the involvement of the hedgehog (Hh) pathway in mastocytosis. GCPS is an extremely rare syndrome resulting from haploinsufficiency of GLI3, the major repressor of Hh family members. From these familial cases of mastocytosis, we demonstrate that the Hh pathway is barely active in normal primary MCs and is overactive in neoplastic MCs. GLI3 and KIT mutations had a synergistic, tumorigenic effect on the onset of mastocytosis in a GCPS mouse model. Finally, Hh inhibitors suppressed neoplastic MC proliferation in\u00a0vitro and extend the survival time of mice with aggressive systemic mastocytosis (ASM). This work revealed, for the first time, the involvement of Hh signaling in the pathophysiology of mastocytosis and demonstrated the cooperative effects of the KIT and Hh oncogenic pathways in mice with ASM, leading to the identification of new promising therapeutic targets.<\/jats:p>","DOI":"10.1182\/blood.2020010207","type":"journal-article","created":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T18:10:12Z","timestamp":1629742212000},"page":"2396-2407","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":12,"title":["The association of Greig syndrome and mastocytosis reveals the involvement of the hedgehog pathway in advanced mastocytosis"],"prefix":"10.1182","volume":"138","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5142-6234","authenticated-orcid":false,"given":"L.","family":"Polivka","sequence":"first","affiliation":[{"name":"Laboratory of Molecular Mechanisms of Hematologic Disorders and Therapeutic Implications, INSERM Unit\u00e9 Mixte de Recherche (UMR) 1163, Paris-Centre University, Imagine Institute, Paris, France;"},{"name":"Department of Dermatology, Reference Center for Genodermatoses (MAGEC), H\u00f4pital Necker-Enfants Malades, Assistance Publique\u2013H\u00f4pitaux de Paris (AP-HP), Paris, France;"},{"name":"Centre de R\u00e9f\u00e9rence Maladies Rares des Mastocytoses (CEREMAST), Necker-Enfants Malades Hospital, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Parietti","sequence":"additional","affiliation":[{"name":"Department of Animal Experimentation, Institut Universitaire d\u2019H\u00e9matologie, Universit\u00e9 Paris Diderot, Sorbonne Paris Cit\u00e9, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Bruneau","sequence":"additional","affiliation":[{"name":"Department of Pathology, H\u00f4pital Necker-Enfants Malades, AP-HP, Paris-Centre University, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Soucie","sequence":"additional","affiliation":[{"name":"Centre de Recherche en Canc\u00e9rologie de Marseille, INSERM U1068, Marseille, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Madrange","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Mechanisms of Hematologic Disorders and Therapeutic Implications, INSERM Unit\u00e9 Mixte de Recherche (UMR) 1163, Paris-Centre University, Imagine Institute, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Bayard","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Mechanisms of Hematologic Disorders and Therapeutic Implications, INSERM Unit\u00e9 Mixte de Recherche (UMR) 1163, Paris-Centre University, Imagine Institute, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Rignault","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Mechanisms of Hematologic Disorders and Therapeutic Implications, INSERM Unit\u00e9 Mixte de Recherche (UMR) 1163, Paris-Centre University, Imagine Institute, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Canioni","sequence":"additional","affiliation":[{"name":"Department of Pathology, H\u00f4pital Necker-Enfants Malades, AP-HP, Paris-Centre University, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Fraitag","sequence":"additional","affiliation":[{"name":"Department of Pathology, H\u00f4pital Necker-Enfants Malades, AP-HP, Paris-Centre University, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Lhermitte","sequence":"additional","affiliation":[{"name":"Institut Necker-Enfants Malades, Universit\u00e9 de Paris, INSERM Unit\u00e9 (U)1151, Paris, France;"},{"name":"Laboratory of Onco-Hematology, H\u00f4pital Universitaire Necker Enfants-Malades, AP-HP, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Feroul","sequence":"additional","affiliation":[{"name":"Institut Necker-Enfants Malades, Universit\u00e9 de Paris, INSERM Unit\u00e9 (U)1151, Paris, France;"},{"name":"Laboratory of Onco-Hematology, H\u00f4pital Universitaire Necker Enfants-Malades, AP-HP, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Tissandier","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Mechanisms of Hematologic Disorders and Therapeutic Implications, INSERM Unit\u00e9 Mixte de Recherche (UMR) 1163, Paris-Centre University, Imagine Institute, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3052-1424","authenticated-orcid":false,"given":"J.","family":"Rossignol","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Mechanisms of Hematologic Disorders and Therapeutic Implications, INSERM Unit\u00e9 Mixte de Recherche (UMR) 1163, Paris-Centre University, Imagine Institute, Paris, France;"},{"name":"Centre de R\u00e9f\u00e9rence Maladies Rares des Mastocytoses (CEREMAST), Necker-Enfants Malades Hospital, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6085-2163","authenticated-orcid":false,"given":"L.","family":"Frenzel","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Mechanisms of Hematologic Disorders and Therapeutic Implications, INSERM Unit\u00e9 Mixte de Recherche (UMR) 1163, Paris-Centre University, Imagine Institute, Paris, France;"},{"name":"Centre de R\u00e9f\u00e9rence Maladies Rares des Mastocytoses (CEREMAST), Necker-Enfants Malades Hospital, Paris, France;"},{"name":"Department of Hematology, Necker-Enfants Malades Hospital, AP-HP, Paris-Centre University, Imagine Institute, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Cagnard","sequence":"additional","affiliation":[{"name":"Bioinformatics, Platform Bioinformatics, INSERM U1163, Paris-Centre University, Imagine Institute, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Meni","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Reference Center for Genodermatoses (MAGEC), H\u00f4pital Necker-Enfants Malades, Assistance Publique\u2013H\u00f4pitaux de Paris (AP-HP), Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Bouktit","sequence":"additional","affiliation":[{"name":"Centre de R\u00e9f\u00e9rence Maladies Rares des Mastocytoses (CEREMAST), Necker-Enfants Malades Hospital, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.-F.","family":"Collange","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Mechanisms of Hematologic Disorders and Therapeutic Implications, INSERM Unit\u00e9 Mixte de Recherche (UMR) 1163, Paris-Centre University, Imagine Institute, Paris, France;"},{"name":"Centre de R\u00e9f\u00e9rence Maladies Rares des Mastocytoses (CEREMAST), Necker-Enfants Malades Hospital, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Gougoula","sequence":"additional","affiliation":[{"name":"Central Unit for Animal Research and Animal Welfare Affairs (ZETT), Heinrich-Heine-University of D\u00fcsseldorf, D\u00fcsseldorf, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Parisot","sequence":"additional","affiliation":[{"name":"Genomics Core Facility, Institut Imagine-Structure F\u00e9d\u00e9rative de Recherche Necker, INSERM U1163 et INSERM US24\/Centre National de la Recherche Scientifique\u00a0(CNRS) Unit\u00e9 Mixte de Service (UMS)3633, Paris-Centre University, Imagine Institute, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Bader-Meunier","sequence":"additional","affiliation":[{"name":"Department of Pediatric Immunology and Hematology, Necker-Enfants Malades Hospital, AP-HP, INSERM U1163, Paris-Centre University, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5275-6868","authenticated-orcid":false,"given":"C.","family":"Livideanu","sequence":"additional","affiliation":[{"name":"Service de Dermatologie, CEREMAST, CHU de Toulouse;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Laurent","sequence":"additional","affiliation":[{"name":"Service d\u2019Anatomie-Pathologique, Oncopole, Centre Hospitalier de Universitaire (CJU) de Toulouse, Toulouse, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Arock","sequence":"additional","affiliation":[{"name":"Centre de R\u00e9f\u00e9rence Maladies Rares des Mastocytoses (CEREMAST), Necker-Enfants Malades Hospital, Paris, France;"},{"name":"Centre de Recherche des Cordeliers, INSERM Unit\u00e9 de Recherche Mixte en Sant\u00e9 (UMRS)1138, Paris, France;"},{"name":"Laboratory of Hematology, Piti\u00e9-Salp\u00eatri\u00e8re Hospital, AP-HP Sorbonne Universit\u00e9, Paris, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Hadj-Rabia","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Reference Center for Genodermatoses (MAGEC), H\u00f4pital Necker-Enfants Malades, Assistance Publique\u2013H\u00f4pitaux de Paris (AP-HP), Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"R\u00fcther","sequence":"additional","affiliation":[{"name":"Institute of Animal Developmental and Molecular Biology, Heinrich Heine University, D\u00fcsseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Dubreuil","sequence":"additional","affiliation":[{"name":"Centre de Recherche en Canc\u00e9rologie de Marseille, INSERM U1068, Marseille, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Bodemer","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Reference Center for Genodermatoses (MAGEC), H\u00f4pital Necker-Enfants Malades, Assistance Publique\u2013H\u00f4pitaux de Paris (AP-HP), Paris, France;"},{"name":"Centre de R\u00e9f\u00e9rence Maladies Rares des Mastocytoses (CEREMAST), Necker-Enfants Malades Hospital, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Hermine","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Mechanisms of Hematologic Disorders and Therapeutic Implications, INSERM Unit\u00e9 Mixte de Recherche (UMR) 1163, Paris-Centre University, Imagine Institute, Paris, France;"},{"name":"Centre de R\u00e9f\u00e9rence Maladies Rares des Mastocytoses (CEREMAST), Necker-Enfants Malades Hospital, Paris, France;"},{"name":"Department of Hematology, Necker-Enfants Malades Hospital, AP-HP, Paris-Centre University, Imagine Institute, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5747-9719","authenticated-orcid":false,"given":"L.","family":"Maouche-Chr\u00e9tien","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Mechanisms of Hematologic Disorders and Therapeutic Implications, INSERM Unit\u00e9 Mixte de Recherche (UMR) 1163, Paris-Centre University, Imagine Institute, Paris, France;"},{"name":"Department of Dermatology, Reference Center for Genodermatoses (MAGEC), H\u00f4pital Necker-Enfants Malades, Assistance Publique\u2013H\u00f4pitaux de Paris (AP-HP), Paris, France;"},{"name":"Centre de R\u00e9f\u00e9rence Maladies Rares des Mastocytoses (CEREMAST), Necker-Enfants Malades Hospital, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"11","key":"2021120916263709600_B1","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1182\/blood-2016-09-731893","article-title":"Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts","volume":"129","author":"Valent","year":"2017","journal-title":"Blood."},{"issue":"6","key":"2021120916263709600_B2","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1158\/0008-5472.CAN-16-2234","article-title":"Advances in the Classification and Treatment of Mastocytosis: Current Status and Outlook toward the Future","volume":"77","author":"Valent","year":"2017","journal-title":"Cancer Res."},{"issue":"4","key":"2021120916263709600_B3","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1073\/pnas.96.4.1609","article-title":"Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis","volume":"96","author":"Longley","year":"1999","journal-title":"Proc Natl Acad Sci USA."},{"issue":"11","key":"2021120916263709600_B4","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1002\/ajh.24553","article-title":"Systemic mastocytosis in adults: 2017 update on diagnosis, risk stratification and management","volume":"91","author":"Pardanani","year":"2016","journal-title":"Am J Hematol."},{"issue":"10","key":"2021120916263709600_B5","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1093\/annonc\/mdx290","article-title":"Midostaurin: a magic bullet that blocks mast cell expansion and activation","volume":"28","author":"Valent","year":"2017","journal-title":"Ann Oncol."},{"issue":"6","key":"2021120916263709600_B6","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1182\/blood-2008-11-189605","article-title":"Mast cell hyperplasia, B-cell malignancy, and intestinal inflammation in mice with conditional expression of a constitutively active kit","volume":"117","author":"Gerbaulet","year":"2011","journal-title":"Blood."},{"issue":"10","key":"2021120916263709600_B7","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.leukres.2014.07.010","article-title":"Familial systemic mastocytosis with germline KIT K509I mutation is sensitive to treatment with imatinib, dasatinib and PKC412","volume":"38","author":"de Melo Campos","year":"2014","journal-title":"Leuk Res."},{"issue":"5","key":"2021120916263709600_B8","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/leu.2009.37","article-title":"Frequent TET2 mutations in systemic mastocytosis: clinical, KITD816V and FIP1L1-PDGFRA correlates","volume":"23","author":"Tefferi","year":"2009","journal-title":"Leukemia."},{"issue":"24","key":"2021120916263709600_B9","doi-asserted-by":"crossref","first-page":"4846","DOI":"10.1182\/blood-2011-12-397588","article-title":"In aggressive forms of mastocytosis, TET2 loss cooperates with c-KITD816V to transform mast cells","volume":"120","author":"Soucie","year":"2012","journal-title":"Blood."},{"issue":"1","key":"2021120916263709600_B10","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/leu.2015.284","article-title":"Additional mutations in SRSF2, ASXL1 and\/or RUNX1 identify a high-risk group of patients with KIT D816V(+) advanced systemic mastocytosis","volume":"30","author":"Jawhar","year":"2016","journal-title":"Leukemia."},{"issue":"9","key":"2021120916263709600_B11","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/ajh.24426","article-title":"Next-generation sequencing in systemic mastocytosis: Derivation of a mutation-augmented clinical prognostic model for survival","volume":"91","author":"Pardanani","year":"2016","journal-title":"Am J Hematol."},{"issue":"5","key":"2021120916263709600_B12","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1038\/leu.2015.4","article-title":"Molecular profiling of myeloid progenitor cells in multi-mutated advanced systemic mastocytosis identifies KIT D816V as a distinct and late event","volume":"29","author":"Jawhar","year":"2015","journal-title":"Leukemia."},{"issue":"14","key":"2021120916263709600_B13","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1182\/blood-2013-04-496448","article-title":"Comprehensive mutational profiling in advanced systemic mastocytosis","volume":"122","author":"Schwaab","year":"2013","journal-title":"Blood."},{"issue":"10","key":"2021120916263709600_B14","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/nrc2503","article-title":"Basal cell carcinomas: attack of the hedgehog","volume":"8","author":"Epstein","year":"2008","journal-title":"Nat Rev Cancer."},{"issue":"18","key":"2021120916263709600_B15","doi-asserted-by":"crossref","first-page":"4883","DOI":"10.1158\/1078-0432.CCR-11-2509","article-title":"Molecular pathways: the hedgehog signaling pathway in cancer","volume":"18","author":"McMillan","year":"2012","journal-title":"Clin Cancer Res."},{"issue":"26","key":"2021120916263709600_B16","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1182\/blood-2016-05-718585","article-title":"GLI3 repressor determines Hedgehog pathway activation and is required for response to SMO antagonist glasdegib in AML","volume":"129","author":"Chaudhry","year":"2017","journal-title":"Blood."},{"issue":"291","key":"2021120916263709600_B17","doi-asserted-by":"crossref","first-page":"291ra96","DOI":"10.1126\/scitranslmed.aaa5731","article-title":"Integration of Hedgehog and mutant FLT3 signaling in myeloid leukemia","volume":"7","author":"Lim","year":"2015","journal-title":"Sci Transl Med."},{"key":"2021120916263709600_B18","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.21037\/atm.2016.10.29","article-title":"Rational for targeting the hedgehog signalling pathway in acute myeloid leukemia with FLT3 mutation","volume":"4","author":"Bouscary","year":"2016","journal-title":"Ann Transl Med."},{"issue":"12","key":"2021120916263709600_B19","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/nrc1229","article-title":"Hedgehog signalling in cancer formation and maintenance","volume":"3","author":"Pasca di Magliano","year":"2003","journal-title":"Nat Rev Cancer."},{"issue":"7239","key":"2021120916263709600_B20","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nature07737","article-title":"Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia [published correction appears in Nature. 2009;460(7255):652]","volume":"458","author":"Zhao","year":"2009","journal-title":"Nature."},{"issue":"1","key":"2021120916263709600_B21","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1182\/blood-2013-10-534685","article-title":"A new human mast cell line expressing a functional IgE receptor converts to tumorigenic growth by KIT D816V transfection","volume":"124","author":"Saleh","year":"2014","journal-title":"Blood."},{"issue":"1","key":"2021120916263709600_B22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1046\/j.1365-2567.2003.01559.x","article-title":"Functional and phenotypic studies of two variants of a human mast cell line with a distinct set of mutations in the c-kit proto-oncogene","volume":"108","author":"Sundstr\u00f6m","year":"2003","journal-title":"Immunology."},{"issue":"7","key":"2021120916263709600_B23","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1182\/blood-2009-06-226027","article-title":"Pediatric mastocytosis-associated KIT extracellular domain mutations exhibit different functional and signaling properties compared with KIT-phosphotransferase domain mutations","volume":"116","author":"Yang","year":"2010","journal-title":"Blood."},{"issue":"3","key":"2021120916263709600_B24","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/ng0393-241","article-title":"A mouse model of greig cephalopolysyndactyly syndrome: the extra-toesJ mutation contains an intragenic deletion of the Gli3 gene [published correction appears in Nat Genet 1998 Aug;19(4):404]","volume":"3","author":"Hui","year":"1993","journal-title":"Nat Genet."},{"key":"2021120916263709600_B25","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1017\/erm.2015.3","article-title":"Cooperative integration between HEDGEHOG-GLI signalling and other oncogenic pathways: implications for cancer therapy","volume":"17","author":"Pandolfi","year":"2015","journal-title":"Expert Rev Mol Med."},{"issue":"6","key":"2021120916263709600_B26","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S1470-2045(15)70100-2","article-title":"Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial","volume":"16","author":"Migden","year":"2015","journal-title":"Lancet Oncol."},{"issue":"1","key":"2021120916263709600_B27","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1080\/14756366.2017.1419221","article-title":"Chemical, computational and functional insights into the chemical stability of the Hedgehog pathway inhibitor GANT61","volume":"33","author":"Calcaterra","year":"2018","journal-title":"J Enzyme Inhib Med Chem."},{"issue":"50","key":"2021120916263709600_B28","doi-asserted-by":"crossref","first-page":"82985","DOI":"10.18632\/oncotarget.12824","article-title":"A new humanized in\u00a0vivo model of KIT D816V+ advanced systemic mastocytosis monitored using a secreted luciferase","volume":"7","author":"Bibi","year":"2016","journal-title":"Oncotarget."},{"issue":"1","key":"2021120916263709600_B29","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12964-017-0163-4","article-title":"Acute myeloid leukemia \u2013 strategies and challenges for targeting oncogenic Hedgehog\/GLI signaling","volume":"15","author":"Aberger","year":"2017","journal-title":"Cell Commun. Signal."},{"issue":"3","key":"2021120916263709600_B30","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ccr.2008.08.003","article-title":"Expansion of Bcr-Abl-positive leukemic stem cells is dependent on Hedgehog pathway activation","volume":"14","author":"Dierks","year":"2008","journal-title":"Cancer Cell."},{"issue":"9","key":"2021120916263709600_B31","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1093\/emboj\/20.9.2214","article-title":"Patched1 interacts with cyclin B1 to regulate cell cycle progression","volume":"20","author":"Barnes","year":"2001","journal-title":"EMBO J."},{"key":"2021120916263709600_B32","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/B978-0-12-394622-5.00002-X","article-title":"Canonical and noncanonical Hedgehog\/GLI signaling in hematological malignancies","volume":"88","author":"Aberger","year":"2012","journal-title":"Vitam Horm."},{"issue":"48","key":"2021120916263709600_B33","doi-asserted-by":"crossref","first-page":"78226","DOI":"10.18632\/oncotarget.12909","article-title":"Hedgehog pathway dysregulation contributes to the pathogenesis of human gastrointestinal stromal tumors via GLI-mediated activation of KIT expression","volume":"7","author":"Tang","year":"2016","journal-title":"Oncotarget."},{"issue":"3","key":"2021120916263709600_B34","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1172\/JCI45523","article-title":"GLI3 repressor controls functional development of the mouse ureter","volume":"121","author":"Cain","year":"2011","journal-title":"J Clin Invest."},{"issue":"5","key":"2021120916263709600_B36","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/j.1349-7006.2009.01111.x","article-title":"Drug resistance is dramatically restored by hedgehog inhibitors in CD34+ leukemic cells","volume":"100","author":"Kobune","year":"2009","journal-title":"Cancer Sci."},{"issue":"6","key":"2021120916263709600_B37","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.leukres.2012.02.012","article-title":"Gli inhibitor GANT61 causes apoptosis in myeloid leukemia cells and acts in synergy with rapamycin","volume":"36","author":"Pan","year":"2012","journal-title":"Leuk Res."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/138\/23\/2396\/1850473\/bloodbld2020010207.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/138\/23\/2396\/1850473\/bloodbld2020010207.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T16:29:21Z","timestamp":1639067361000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/138\/23\/2396\/476649\/The-association-of-Greig-syndrome-and-mastocytosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,9]]},"references-count":36,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2021,12,9]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2020010207","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,9]]}}}